María Fernández-Reyes

María Fernández-Reyes

Auto-generated profile, based on publicly available information

María Fernández-Reyes

Centro de Investigaciones Biológicas (CSIC)

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2011 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
RLRafael López-Rojas
Rafael López-Rojas
JDJuan Domínguez-Herrera
Juan Domínguez-Herrera
MMMichael McConnell
Michael McConnell
FDFernando Docobo-Pérez
Fernando Docobo-Pérez
YSYounes Smani
Younes Smani
JPJerónimo Pachón
Jerónimo Pachón
Acinetobacter baumannii (American Type Culture Collection strain 19606) acquires mutations in the pmrB gene during the in vitro development of resistance to colistin. The colistin-resistant strain has lower affinity for colistin, reduced in vivo fitness (competition index, .016), and decreased virulence, both in terms of mortality (0% lethal dose, 6.9 vs 4.9 log colony-forming units) and survival in a mouse model of peritoneal sepsis. These results may explain the low incidence and dissemination of colistin resistance in A. baumannii in clinical settings.

17 March 2009 in Proteomics
Verified
Journal Article
Closed access
PDF file
MFMaría Fernández‐Reyes
María Fernández‐Reyes
MRManuel Rodríguez‐Falcón
Manuel Rodríguez‐Falcón
CCCristina Chiva
Cristina Chiva
JPJerónimo Pachón
Jerónimo Pachón
David AndreuDavid Andreu
David Andreu
LRLuis Rivas
Luis Rivas

1 April 2006 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
JSJose Maria Saugar
Jose Maria Saugar
MRMaría Jesús RodrígUez-HernánDez
María Jesús RodrígUez-HernánDez
Beatriz G. de la TorreBeatriz G. de la Torre
Beatriz G. de la Torre
MPMaría Eugenia Pachón-IbañeZ
María Eugenia Pachón-IbañeZ
MFMaría FernánDez-Reyes
María FernánDez-Reyes
LRLuis Rivas
Luis Rivas
Acinetobacter baumannii has successfully developed resistance against all common antibiotics, including colistin (polymyxin E), the last universally active drug against this pathogen. The possible widespread distribution of colistin-resistant A. baumannii strains may create an alarming clinical situation. In a previous work, we reported differences in lethal mechanisms between polymyxin B (PXB) and the cecropin A-melittin (CA-M) hybrid peptide CA(1-8)M(1-18) (KWKLFKKIGIGAVLKVLTTGLPALIS-NH 2 ) on colistin-susceptible strains (J. M. Saugar, T. Alarcón, S. López-Hernández, M. López-Brea, D. Andreu, and L. Rivas, Antimicrob. Agents Chemother. 46: 875-878, 2002). We now demonstrate that CA(1-8)M(1-18) and three short analogues, namely CA(1-7)M(2-9) (KWKLFKKIGAVLKVL-NH 2 ), its N α -octanoyl derivative (Oct-KWKLFKKIGAVLKVL-NH 2 ), and CA(1-7)M(5-9) (KWKLLKKIGAVLKVL-NH 2 ) are active against two colistin-resistant clinical strains. In vitro, resistance to colistin sulfate was targeted to the outer membrane, as spheroplasts were equally lysed by a given peptide, regardless of their respective level of colistin resistance. The CA-M hybrids were more efficient than colistin in displacing lipopolysaccharide-bound dansyl-polymyxin B from colistin-resistant but not from colistin-susceptible strains. Similar improved performance of the CA-M hybrids in permeation of the inner membrane was observed, regardless of the resistance pattern of the strain. These results argue in favor of a possible use of CA-M peptides, and by extension other antimicrobial peptides with similar features, as alternative chemotherapy in colistin-resistant Acinetobacter infections.

8 January 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSConcepción Solanas
Concepción Solanas
Beatriz G. de la TorreBeatriz G. de la Torre
Beatriz G. de la Torre
MFMaría Fernández-Reyes
María Fernández-Reyes
CSClara M. Santiveri
Clara M. Santiveri
M Angeles JimenezM Angeles Jimenez
M Angeles Jimenez
CCCarlos Cativiela
Carlos Cativiela

1 March 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MFMaría Fernández-Reyes
María Fernández-Reyes
DVDiego Vicente
Diego Vicente
MGMaría Gomariz
María Gomariz
OEOlatz Esnal
Olatz Esnal
JLJoseba Landa
Joseba Landa
EPEmilio Pérez-Trallero
Emilio Pérez-Trallero
The prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBLPE) was studied in stool samples from 125 8- to 16-month-old healthy children. Twenty-four percent of them and 10.7% of the 318 fecal samples studied yielded extended-spectrum-β-lactamase-producing Escherichia coli, with the types being SHV-12, CTX-M-1, CTX-M-14, and TEM-52, the most common types of β-lactamases. This high prevalence of ESBLPE in healthy people, which is to our knowledge the highest currently reported in Europe, may represent a risk for increased infections by these organisms in the future.

22 April 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSConcepción Solanas
Concepción Solanas
Beatriz G. de la TorreBeatriz G. de la Torre
Beatriz G. de la Torre
MFMaría Fernández-Reyes
María Fernández-Reyes
CSClara M. Santiveri
Clara M. Santiveri
M Angeles JimenezM Angeles Jimenez
M Angeles Jimenez
CCCarlos Cativiela
Carlos Cativiela